Most people with cystic fibrosis (CF) responding to a U.S.-based online survey were generally satisfied with their treatment plan and…
Articles by Marta Figueiredo, PhD
The introduction of CFTR modulators — a type of disease-modifying treatment for cystic fibrosis (CF) caused by specific…
More than half of children and teens with cystic fibrosis (CF) who do not show breathing difficulties during physical…
The Cystic Fibrosis Foundation (CFF) has appointed Steven Rowe, MD, from the University of Alabama at Birmingham, as its…
The triple combination therapy Kaftrio restores the function of CFTR — the defective protein in cystic fibrosis (CF) —…
Cystic fibrosis (CF) patients show a shift in gut microbiota composition toward more abundant, rarer populations that is significantly…
Both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have granted orphan drug status to…
An orally available small molecule called XL147 rescued the function of CFTR — the faulty protein in cystic fibrosis…
One year of Trikafta treatment increases the blood levels of vitamin D in people with cystic fibrosis (CF)…
People with cystic fibrosis (CF) in the U.K. are now living longer, with the life expectancy of children born today…